KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) FCF Margin (2016 - 2025)

Pfizer (PFE) has disclosed FCF Margin for 17 consecutive years, with 25.65% as the latest value for Q4 2025.

  • Quarterly FCF Margin changed N/A to 25.65% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 18.82% through Dec 2025, up 1183.0% year-over-year, with the annual reading at 14.5% for FY2025, 10275.0% down from the prior year.
  • FCF Margin for Q4 2025 was 25.65% at Pfizer, down from 174.11% in the prior quarter.
  • The five-year high for FCF Margin was 911.99% in Q3 2024, with the low at 60.8% in Q3 2023.
  • Average FCF Margin over 5 years is 88.43%, with a median of 25.65% recorded in 2025.
  • The sharpest move saw FCF Margin soared 89238bps in 2024, then plummeted -73788bps in 2025.
  • Over 5 years, FCF Margin stood at 103.84% in 2021, then dropped by -22bps to 81.5% in 2022, then soared by 50bps to 122.19% in 2023, then skyrocketed by 646bps to 911.99% in 2024, then plummeted by -97bps to 25.65% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 25.65%, 174.11%, and 8.19% for Q4 2025, Q3 2025, and Q2 2025 respectively.